<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1989-07-01" modified="2020-10-07" version="189">
<accession>P09693</accession>
<accession>Q2HIZ6</accession>
<name>CD3G_HUMAN</name>
<protein>
<recommendedName>
<fullName>T-cell surface glycoprotein CD3 gamma chain</fullName>
</recommendedName>
<alternativeName>
<fullName>T-cell receptor T3 gamma chain</fullName>
</alternativeName>
<cdAntigenName>CD3g</cdAntigenName>
</protein>
<gene>
<name type="primary">CD3G</name>
<name type="synonym">T3G</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1986" name="EMBO J." volume="5" first="1799" last="1808">
<title>Primary structure of the T3 gamma subunit of the T3/T cell antigen receptor complex deduced from cDNA sequences: evolution of the T3 gamma and delta subunits.</title>
<authorList>
<person name="Krissansen G.W."/>
<person name="Owen M.J."/>
<person name="Verbi W."/>
<person name="Crumpton M.J."/>
</authorList>
<dbReference type="PubMed" id="2944745"/>
<dbReference type="DOI" id="10.1002/j.1460-2075.1986.tb04429.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1987" name="EMBO J." volume="6" first="2953" last="2957">
<title>Physical linkage of three CD3 genes on human chromosome 11.</title>
<authorList>
<person name="Tunnacliffe A."/>
<person name="Buluwela L."/>
<person name="Rabbitts T.H."/>
</authorList>
<dbReference type="PubMed" id="2826124"/>
<dbReference type="DOI" id="10.1002/j.1460-2075.1987.tb02600.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1989" name="Eur. J. Biochem." volume="181" first="55" last="65">
<title>Dephosphorylation of the human T lymphocyte CD3 antigen.</title>
<authorList>
<person name="Alexander D."/>
<person name="Goris J."/>
<person name="Marais R."/>
<person name="Rothbard J."/>
<person name="Merlevede W."/>
<person name="Crumpton M.J."/>
</authorList>
<dbReference type="PubMed" id="2540970"/>
<dbReference type="DOI" id="10.1111/j.1432-1033.1989.tb14693.x"/>
</citation>
<scope>PROTEIN SEQUENCE OF 139-182</scope>
<scope>PHOSPHORYLATION AT SER-145 AND SER-148</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1987" name="J. Biol. Chem." volume="262" first="10918" last="10921">
<title>The human T3 gamma chain is phosphorylated at serine 126 in response to T lymphocyte activation.</title>
<authorList>
<person name="Davies A.A."/>
<person name="Cantrell D.A."/>
<person name="Hexham J.M."/>
<person name="Parker P.J."/>
<person name="Rothbard J."/>
<person name="Crumpton M.J."/>
</authorList>
<dbReference type="PubMed" id="3112151"/>
</citation>
<scope>PHOSPHORYLATION AT SER-145 AND SER-148</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1989" name="Proc. Natl. Acad. Sci. U.S.A." volume="86" first="3277" last="3281">
<title>The CD4 and CD8 antigens are coupled to a protein-tyrosine kinase (p56lck) that phosphorylates the CD3 complex.</title>
<authorList>
<person name="Barber E.K."/>
<person name="Dasgupta J.D."/>
<person name="Schlossman S.F."/>
<person name="Trevillyan J.M."/>
<person name="Rudd C.E."/>
</authorList>
<dbReference type="PubMed" id="2470098"/>
<dbReference type="DOI" id="10.1073/pnas.86.9.3277"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION BY LCK</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1992" name="Cell" volume="69" first="1143" last="1157">
<title>A novel di-leucine motif and a tyrosine-based motif independently mediate lysosomal targeting and endocytosis of CD3 chains.</title>
<authorList>
<person name="Letourneur F."/>
<person name="Klausner R.D."/>
</authorList>
<dbReference type="PubMed" id="1535555"/>
<dbReference type="DOI" id="10.1016/0092-8674(92)90636-q"/>
</citation>
<scope>MUTAGENESIS OF LEU-153; LEU-154; TYR-160 AND LEU-163</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1992" name="N. Engl. J. Med." volume="327" first="529" last="533">
<title>Brief report: primary immunodeficiency caused by mutations in the gene encoding the CD3-gamma subunit of the T-lymphocyte receptor.</title>
<authorList>
<person name="Arnaiz-Villena A."/>
<person name="Timon M."/>
<person name="Corell A."/>
<person name="Perez-Aciego P."/>
<person name="Martin-Villa J.M."/>
<person name="Regueiro J.R."/>
</authorList>
<dbReference type="PubMed" id="1635567"/>
<dbReference type="DOI" id="10.1056/nejm199208203270805"/>
</citation>
<scope>INVOLVEMENT IN IMD17</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1994" name="EMBO J." volume="13" first="2156" last="2166">
<title>CD3 gamma contains a phosphoserine-dependent di-leucine motif involved in down-regulation of the T cell receptor.</title>
<authorList>
<person name="Dietrich J."/>
<person name="Hou X."/>
<person name="Wegener A.M."/>
<person name="Geisler C."/>
</authorList>
<dbReference type="PubMed" id="8187769"/>
<dbReference type="DOI" id="10.1002/j.1460-2075.1994.tb06492.x"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION AT SER-148</scope>
<scope>MUTAGENESIS OF LEU-153 AND LEU-154</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1996" name="J. Cell Biol." volume="132" first="299" last="310">
<title>Role of CD3 gamma in T cell receptor assembly.</title>
<authorList>
<person name="Dietrich J."/>
<person name="Neisig A."/>
<person name="Hou X."/>
<person name="Wegener A.M."/>
<person name="Gajhede M."/>
<person name="Geisler C."/>
</authorList>
<dbReference type="PubMed" id="8636209"/>
<dbReference type="DOI" id="10.1083/jcb.132.3.299"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>GLYCOSYLATION AT ASN-52 AND ASN-92</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2004" name="Crit. Rev. Immunol." volume="24" first="67" last="86">
<title>TCR trafficking in resting and stimulated T cells.</title>
<authorList>
<person name="Geisler C."/>
</authorList>
<dbReference type="PubMed" id="14995914"/>
<dbReference type="DOI" id="10.1615/critrevimmunol.v24.i1.30"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2007" name="J. Immunol." volume="178" first="2556" last="2564">
<title>Differential biological role of CD3 chains revealed by human immunodeficiencies.</title>
<authorList>
<person name="Recio M.J."/>
<person name="Moreno-Pelayo M.A."/>
<person name="Kilic S.S."/>
<person name="Guardo A.C."/>
<person name="Sanal O."/>
<person name="Allende L.M."/>
<person name="Perez-Flores V."/>
<person name="Mencia A."/>
<person name="Modamio-Hoeybjoer S."/>
<person name="Seoane E."/>
<person name="Regueiro J.R."/>
</authorList>
<dbReference type="PubMed" id="17277165"/>
<dbReference type="DOI" id="10.4049/jimmunol.178.4.2556"/>
</citation>
<scope>INVOLVEMENT IN IMD17</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="14">
<citation type="journal article" date="2004" name="Proc. Natl. Acad. Sci. U.S.A." volume="101" first="7675" last="7680">
<title>Crystal structure of the human T cell receptor CD3 epsilon gamma heterodimer complexed to the therapeutic mAb OKT3.</title>
<authorList>
<person name="Kjer-Nielsen L."/>
<person name="Dunstone M.A."/>
<person name="Kostenko L."/>
<person name="Ely L.K."/>
<person name="Beddoe T."/>
<person name="Mifsud N.A."/>
<person name="Purcell A.W."/>
<person name="Brooks A.G."/>
<person name="McCluskey J."/>
<person name="Rossjohn J."/>
</authorList>
<dbReference type="PubMed" id="15136729"/>
<dbReference type="DOI" id="10.1073/pnas.0402295101"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 23-103 IN COMPLEX WITH CD3E AND ANTIBODY</scope>
<scope>SUBUNIT</scope>
<scope>DISULFIDE BOND</scope>
</reference>
<comment type="function">
<text evidence="9 12 13">Part of the TCR-CD3 complex present on T-lymphocyte cell surface that plays an essential role in adaptive immune response. When antigen presenting cells (APCs) activate T-cell receptor (TCR), TCR-mediated signals are transmitted across the cell membrane by the CD3 chains CD3D, CD3E, CD3G and CD3Z. All CD3 chains contain immunoreceptor tyrosine-based activation motifs (ITAMs) in their cytoplasmic domain. Upon TCR engagement, these motifs become phosphorylated by Src family protein tyrosine kinases LCK and FYN, resulting in the activation of downstream signaling pathways (PubMed:2470098). In addition to this role of signal transduction in T-cell activation, CD3G plays an essential role in the dynamic regulation of TCR expression at the cell surface (PubMed:8187769). Indeed, constitutive TCR cycling is dependent on the di-leucine-based (diL) receptor-sorting motif present in CD3G.</text>
</comment>
<comment type="subunit">
<text evidence="5">The TCR-CD3 complex is composed of a CD3D/CD3E and a CD3G/CD3E heterodimers that preferentially associate with TCRalpha and TCRbeta, respectively, to form TCRalpha/CD3E/CD3G and TCRbeta/CD3G/CD3E trimers. In turn, the hexamer interacts with CD3Z homodimer to form the TCR-CD3 complex. Alternatively, TCRalpha and TCRbeta can be replaced by TCRgamma and TCRdelta.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-3862428">
<id>P09693</id>
</interactant>
<interactant intactId="EBI-4319440">
<id>P54849</id>
<label>EMP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-3862428">
<id>P09693</id>
</interactant>
<interactant intactId="EBI-12007212">
<id>Q86UP2-3</id>
<label>KTN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-3862428">
<id>P09693</id>
</interactant>
<interactant intactId="EBI-8070286">
<id>O43561-2</id>
<label>LAT</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-3862428">
<id>P09693</id>
</interactant>
<interactant intactId="EBI-3932027">
<id>P21145</id>
<label>MAL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-3862428">
<id>P09693</id>
</interactant>
<interactant intactId="EBI-2845982">
<id>Q01453</id>
<label>PMP22</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-3862428">
<id>P09693</id>
</interactant>
<interactant intactId="EBI-741829">
<id>Q96HH6</id>
<label>TMEM19</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-3862428">
<id>P09693</id>
</interactant>
<interactant intactId="EBI-12274070">
<id>Q969S6</id>
<label>TMEM203</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-3862428">
<id>P09693</id>
</interactant>
<interactant intactId="EBI-17180389">
<id>E9PQX1</id>
<label>TMEM262</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-3862428">
<id>P09693</id>
</interactant>
<interactant intactId="EBI-3922833">
<id>Q969K7</id>
<label>TMEM54</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="13">Cell membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="domain">
<text>A di-leucine motif and a tyrosine-based motif are individually sufficient to induce both endocytosis and delivery to lysosomes.</text>
</comment>
<comment type="PTM">
<text evidence="9 12">Phosphorylated on Tyr residues after T-cell receptor triggering by LCK in association with CD4/CD8 (PubMed:2470098). Phosphorylated also by PKC; leading to the TCR complex down-regulation (PubMed:8187769).</text>
</comment>
<comment type="PTM">
<text evidence="2">Phosphorylated on Tyr residues after T-cell receptor triggering by LCK in association with CD4/CD8.</text>
</comment>
<comment type="disease" evidence="7 8">
<disease id="DI-04033">
<name>Immunodeficiency 17</name>
<acronym>IMD17</acronym>
<description>An autosomal recessive primary immunodeficiency characterized by highly variable clinical severity. Some patients have onset of severe recurrent infections in early infancy that may be lethal, whereas others may be only mildly affected or essentially asymptomatic into young adulthood. More severely affected patients may have evidence of autoimmune disease or enteropathy. The immunologic pattern is similar among patients, showing partial T-cell lymphopenia, decreased amounts of the CD3 complex, and impaired proliferative responses to T-cell receptor dependent stimuli. The phenotype in some patients is reminiscent of severe combined immunodeficiency.</description>
<dbReference type="MIM" id="615607"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="online information" name="CD3Gbase">
<link uri="http://structure.bmc.lu.se/idbase/CD3Gbase/"/>
<text>CD3G mutation db</text>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/CD3_receptor"/>
<text>CD3 receptor entry</text>
</comment>
<dbReference type="EMBL" id="X04145">
<property type="protein sequence ID" value="CAA27764.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X06026">
<property type="protein sequence ID" value="CAA29428.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X06027">
<property type="protein sequence ID" value="CAA29428.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X06028">
<property type="protein sequence ID" value="CAA29428.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X06029">
<property type="protein sequence ID" value="CAA29428.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X06030">
<property type="protein sequence ID" value="CAA29428.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X06031">
<property type="protein sequence ID" value="CAA29428.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC113830">
<property type="protein sequence ID" value="AAI13831.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS8395.1"/>
<dbReference type="PIR" id="A25468">
<property type="entry name" value="A25468"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000064.1">
<property type="nucleotide sequence ID" value="NM_000073.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006719004.1">
<property type="nucleotide sequence ID" value="XM_006718941.2"/>
</dbReference>
<dbReference type="PDB" id="1SY6">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=23-103"/>
</dbReference>
<dbReference type="PDB" id="6JXR">
<property type="method" value="EM"/>
<property type="resolution" value="3.70"/>
<property type="chains" value="g=1-182"/>
</dbReference>
<dbReference type="PDBsum" id="1SY6"/>
<dbReference type="PDBsum" id="6JXR"/>
<dbReference type="BMRB" id="P09693"/>
<dbReference type="SMR" id="P09693"/>
<dbReference type="BioGRID" id="107355">
<property type="interactions" value="16"/>
</dbReference>
<dbReference type="ELM" id="P09693"/>
<dbReference type="IntAct" id="P09693">
<property type="interactions" value="10"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000431445"/>
<dbReference type="ChEMBL" id="CHEMBL2364168"/>
<dbReference type="DrugBank" id="DB00075">
<property type="generic name" value="Muromonab"/>
</dbReference>
<dbReference type="DrugCentral" id="P09693"/>
<dbReference type="GlyGen" id="P09693">
<property type="glycosylation" value="2 sites"/>
</dbReference>
<dbReference type="iPTMnet" id="P09693"/>
<dbReference type="PhosphoSitePlus" id="P09693"/>
<dbReference type="BioMuta" id="CD3G"/>
<dbReference type="DMDM" id="115993"/>
<dbReference type="jPOST" id="P09693"/>
<dbReference type="MassIVE" id="P09693"/>
<dbReference type="MaxQB" id="P09693"/>
<dbReference type="PaxDb" id="P09693"/>
<dbReference type="PeptideAtlas" id="P09693"/>
<dbReference type="PRIDE" id="P09693"/>
<dbReference type="ProteomicsDB" id="52266"/>
<dbReference type="ABCD" id="P09693">
<property type="antibodies" value="1 sequenced antibody"/>
</dbReference>
<dbReference type="Antibodypedia" id="4306">
<property type="antibodies" value="339 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000532917">
<property type="protein sequence ID" value="ENSP00000431445"/>
<property type="gene ID" value="ENSG00000160654"/>
</dbReference>
<dbReference type="GeneID" id="917"/>
<dbReference type="KEGG" id="hsa:917"/>
<dbReference type="UCSC" id="uc001psu.3">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="917"/>
<dbReference type="DisGeNET" id="917"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000160654.9"/>
<dbReference type="GeneCards" id="CD3G"/>
<dbReference type="HGNC" id="HGNC:1675">
<property type="gene designation" value="CD3G"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000160654">
<property type="expression patterns" value="Tissue enriched (lymphoid)"/>
</dbReference>
<dbReference type="MalaCards" id="CD3G"/>
<dbReference type="MIM" id="186740">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="615607">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P09693"/>
<dbReference type="OpenTargets" id="ENSG00000160654"/>
<dbReference type="Orphanet" id="169082">
<property type="disease" value="Combined immunodeficiency due to CD3gamma deficiency"/>
</dbReference>
<dbReference type="PharmGKB" id="PA26217"/>
<dbReference type="eggNOG" id="ENOG502S4XC">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000153312"/>
<dbReference type="HOGENOM" id="CLU_115449_0_0_1"/>
<dbReference type="InParanoid" id="P09693"/>
<dbReference type="KO" id="K06452"/>
<dbReference type="OMA" id="DRENDQY"/>
<dbReference type="OrthoDB" id="1466902at2759"/>
<dbReference type="PhylomeDB" id="P09693"/>
<dbReference type="TreeFam" id="TF335892"/>
<dbReference type="PathwayCommons" id="P09693"/>
<dbReference type="Reactome" id="R-HSA-198933">
<property type="pathway name" value="Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-202424">
<property type="pathway name" value="Downstream TCR signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-202427">
<property type="pathway name" value="Phosphorylation of CD3 and TCR zeta chains"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-202430">
<property type="pathway name" value="Translocation of ZAP-70 to Immunological synapse"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-202433">
<property type="pathway name" value="Generation of second messenger molecules"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2029481">
<property type="pathway name" value="FCGR activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2029482">
<property type="pathway name" value="Regulation of actin dynamics for phagocytic cup formation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2029485">
<property type="pathway name" value="Role of phospholipids in phagocytosis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-389948">
<property type="pathway name" value="PD-1 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8856825">
<property type="pathway name" value="Cargo recognition for clathrin-mediated endocytosis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8856828">
<property type="pathway name" value="Clathrin-mediated endocytosis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9664323">
<property type="pathway name" value="FCGR3A-mediated IL10 synthesis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9664422">
<property type="pathway name" value="FCGR3A-mediated phagocytosis"/>
</dbReference>
<dbReference type="SIGNOR" id="P09693"/>
<dbReference type="BioGRID-ORCS" id="917">
<property type="hits" value="5 hits in 869 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="CD3G">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P09693"/>
<dbReference type="GeneWiki" id="CD3G"/>
<dbReference type="GenomeRNAi" id="917"/>
<dbReference type="Pharos" id="P09693">
<property type="development level" value="Tclin"/>
</dbReference>
<dbReference type="PRO" id="PR:P09693"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 11"/>
</dbReference>
<dbReference type="RNAct" id="P09693">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000160654">
<property type="expression patterns" value="Expressed in leukocyte and 134 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P09693">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P09693">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0042105">
<property type="term" value="C:alpha-beta T cell receptor complex"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0030665">
<property type="term" value="C:clathrin-coated vesicle membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0009897">
<property type="term" value="C:external side of plasma membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0042101">
<property type="term" value="C:T cell receptor complex"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0046982">
<property type="term" value="F:protein heterodimerization activity"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030159">
<property type="term" value="F:signaling receptor complex adaptor activity"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042608">
<property type="term" value="F:T cell receptor binding"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004888">
<property type="term" value="F:transmembrane signaling receptor activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002250">
<property type="term" value="P:adaptive immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0007166">
<property type="term" value="P:cell surface receptor signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007163">
<property type="term" value="P:establishment or maintenance of cell polarity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0038096">
<property type="term" value="P:Fc-gamma receptor signaling pathway involved in phagocytosis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0061024">
<property type="term" value="P:membrane organization"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045059">
<property type="term" value="P:positive thymic T cell selection"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0015031">
<property type="term" value="P:protein transport"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0065003">
<property type="term" value="P:protein-containing complex assembly"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050776">
<property type="term" value="P:regulation of immune response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0070228">
<property type="term" value="P:regulation of lymphocyte apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042110">
<property type="term" value="P:T cell activation"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030217">
<property type="term" value="P:T cell differentiation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0050852">
<property type="term" value="P:T cell receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="DisProt" id="DP00508"/>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR015484">
<property type="entry name" value="CD3_esu/gsu/dsu"/>
</dbReference>
<dbReference type="InterPro" id="IPR036179">
<property type="entry name" value="Ig-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR032052">
<property type="entry name" value="Ig_4"/>
</dbReference>
<dbReference type="InterPro" id="IPR003598">
<property type="entry name" value="Ig_sub2"/>
</dbReference>
<dbReference type="InterPro" id="IPR003110">
<property type="entry name" value="Phos_immunorcpt_sig_ITAM"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR10570">
<property type="entry name" value="PTHR10570"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF16680">
<property type="entry name" value="Ig_4"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02189">
<property type="entry name" value="ITAM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00408">
<property type="entry name" value="IGc2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00077">
<property type="entry name" value="ITAM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48726">
<property type="entry name" value="SSF48726"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51055">
<property type="entry name" value="ITAM_1"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-1064">Adaptive immunity</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0393">Immunoglobulin domain</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide">
<location>
<begin position="1"/>
<end position="22"/>
</location>
</feature>
<feature type="chain" description="T-cell surface glycoprotein CD3 gamma chain" id="PRO_0000014615">
<location>
<begin position="23"/>
<end position="182"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="3">
<location>
<begin position="23"/>
<end position="116"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="3">
<location>
<begin position="117"/>
<end position="137"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="3">
<location>
<begin position="138"/>
<end position="182"/>
</location>
</feature>
<feature type="domain" description="Ig-like">
<location>
<begin position="37"/>
<end position="94"/>
</location>
</feature>
<feature type="domain" description="ITAM" evidence="4">
<location>
<begin position="149"/>
<end position="177"/>
</location>
</feature>
<feature type="short sequence motif" description="Di-leucine motif" evidence="12">
<location>
<begin position="153"/>
<end position="154"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10 11">
<location>
<position position="145"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PKC" evidence="10 11 12">
<location>
<position position="148"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="13">
<location>
<position position="52"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="13">
<location>
<position position="92"/>
</location>
</feature>
<feature type="disulfide bond" evidence="5">
<location>
<begin position="46"/>
<end position="87"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3753058." id="VAR_049854">
<original>V</original>
<variation>F</variation>
<location>
<position position="131"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes lysosomal targeting." evidence="6 12">
<original>L</original>
<variation>A</variation>
<location>
<position position="153"/>
</location>
</feature>
<feature type="mutagenesis site" description="Diminished but persistent lysosomal targeting." evidence="6">
<original>L</original>
<variation>I</variation>
<location>
<position position="153"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes lysosomal targeting." evidence="12">
<original>L</original>
<variation>A</variation>
<location>
<position position="154"/>
</location>
</feature>
<feature type="mutagenesis site" description="Diminished but persistent lysosomal targeting." evidence="6">
<original>L</original>
<variation>A</variation>
<location>
<position position="154"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect." evidence="6">
<original>L</original>
<variation>I</variation>
<location>
<position position="154"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes lysosomal targeting." evidence="6">
<original>Y</original>
<variation>A</variation>
<location>
<position position="160"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes lysosomal targeting." evidence="6">
<original>L</original>
<variation>A</variation>
<location>
<position position="163"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="26"/>
<end position="28"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="31"/>
<end position="33"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="38"/>
<end position="46"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="50"/>
<end position="57"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="60"/>
<end position="68"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="72"/>
<end position="76"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="77"/>
<end position="79"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="82"/>
<end position="92"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="97"/>
<end position="102"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1SY6"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P04234"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000255"/>
<evidence key="4" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00379"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15136729"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1535555"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1635567"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17277165"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2470098"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2540970"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3112151"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8187769"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8636209"/>
</source>
</evidence>
<sequence length="182" mass="20469" checksum="EE65C0186FB9872B" modified="1989-07-01" version="1" precursor="true">MEQGKGLAVLILAIILLQGTLAQSIKGNHLVKVYDYQEDGSVLLTCDAEAKNITWFKDGKMIGFLTEDKKKWNLGSNAKDPRGMYQCKGSQNKSKPLQVYYRMCQNCIELNAATISGFLFAEIVSIFVLAVGVYFIAGQDGVRQSRASDKQTLLPNDQLYQPLKDREDDQYSHLQGNQLRRN</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

